Name
IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
Mode of Action
IT HAS A BROAD SPECTRUM OF IGG ANTIBODIES AGAINST BACTERIAL AND VIRAL AGENTS THAT ARE CAPABLE OF OPSONIZATION AND NEUTRALIZATION OF MICROBES AND TOXINS
Dosage
PRIMARY ID :- 0.2-0.8 GM/KG ONCE IN 3-4 WEEKS. SECONDARY ID :- 0.2-0.4 GM/KG EVERY 3 OR 4 WEEKS ; ALLOGRAFT BONE MARROW RECEIPIENTS - 9.5 GM/KG EVERY WEEK FOR 3 MONTHS STARTING 7 DAYS BEFORE TRANSPIANT. THEN MONTHLY FOR 9 MONTHS ; ITP -0.4 GM/KG/DAY FOR FIRST 5 DAYS OR 0.4 GM/KG ON 2 DAYS. FOLLOWED 0.4 GM/KG EVERY 1-4 WEEKS. SEVERE INFECTION :- 0.4-1.0 GM/KG DAILY FOR 1-4 DAYS.
Drug Group
[HUMAN SOURCE] , [IMMUNOGLOBULIN]
Cross Reaction
VACCINE SUCH AS MEASLES, MUMPS, POLIO, CHICKEN POX AND REBELLA SHOULD BE USED AFTER 3 MONTHS OF TETANUS IMMUNE GLOBULIN ADMINISTRATION SINCE ANTIBODIES IN IMMUNE GLUBULIN PREPARATIONS MAY INTERFERE WITH PATIENT RESPONSES TO LIVE VACCINES.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph